Differding Consulting s.p.r.l. was established in 2010 to offer strategic advice on drug discovery activities to pharmaceutical companies, biotech companies and research institutes.
We focus on two areas:
Differding Consulting s.p.r.l. is based in Louvain-la-Neuve (Belgium), South of Brussels, and is building on an expanding global network with contract research organizations, in particular in Asia, and a special focus on India.
29.10.13 | DRUG DISCOVERY ALLIANCES IN INDIA - INDICATIONS, TRAGETS AND NEW CHEMICAL ENTITIES
29.10.13 | HIGHLIGHTS FROM ASMC'13 - ADVANCES IN SYNTHETIC AND MEDICINAL CHEMISTRY - MAY 5-8, 2013, MOSCOW
24.06.13 | BIOTECHNOLOGY IN INDIA – 2013 “BIOSPECTRUM-ABLE” SURVEY
11.06.13 | SAROGLITAZAR – FIRST NCE DISCOVERED AND DEVELOPED IN INDIA TO REACH THE MARKET
25.02.13 | INNOVATIVE DRUG DISCOVERY IN INDIA – THE GROWING INDIAN R&D PIPELINE
Ranbaxy’s recently launched Synriam, together with Glenmark’s (and US partner Salix Pharmaceuticals’) approval of Crofelemer are only the two first visible signs of India’s growing presence in innovative drug discovery and development...
30.07.12 | BIOTECHNOLOGY IN INDIA – 2012 “BIOSPECTRUM-ABLE” SURVEY
According to the tenth annual Indian Biotech Industry survey by Biospectrum-ABLE (Association of Biotechnology Led Enterprises), the Indian biotech industry passed the 4 Billion US$ mark in 2011-12...
03.01.12 | INDIAN DRUG DISCOVERY PIPELINE
In the late nineteen eighties, Indian pharma companies started in-house drug discovery activities, aiming at developing the country’s first home-made drug ...
03.01.12 | PHARMA AND BIOTECHNOLOGY ACTIVITIES IN INDIA
The Indian biotech industry has been booming over the past decade, growing from 0.5 Billion US$ in 2002-03 to more than 3.75 Billion US$ in 2010-11, and counting more than seven hundred players. ...